Clinical trial
Erythrocyte Complement Receptor 1 and Alzheimer Disease
NCT01565434 is registered in ClinicalTrials.gov with CHU de Reims as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Erythrocyte Complement Receptor 1 and Alzheimer Disease
- Lead sponsor
- CHU de Reims
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 29, 2012
- Completion date
- April 30, 2015
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.